Bard Associates’s Vivos Therapeutics VVOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,068
| Closed | -$68.8K | – | 192 |
|
|
2023
Q1 | $68.8K | Hold |
8,068
| – | – | 0.03% | 177 |
|
|
2022
Q4 | $81.1K | Sell |
8,068
-600
| -7% | -$6.03K | 0.03% | 177 |
|
|
2022
Q3 | $141K | Hold |
8,668
| – | – | 0.06% | 162 |
|
|
2022
Q2 | $280K | Buy |
8,668
+160
| +2% | +$5.17K | 0.12% | 141 |
|
|
2022
Q1 | $570K | Sell |
8,508
-32
| -0.4% | -$2.14K | 0.2% | 122 |
|
|
2021
Q4 | $480K | Sell |
8,540
-80
| -0.9% | -$4.5K | 0.16% | 135 |
|
|
2021
Q3 | $871K | Hold |
8,620
| – | – | 0.29% | 109 |
|
|
2021
Q2 | $1.07M | Buy |
+8,620
| New | +$1.07M | 0.35% | 99 |
|